Perioperative infection prophylaxis and risk factor impact in colon surgery

Chemotherapy

Volumn 46, Issue 5, 2000, Pages 353-363

  Rau, H G ^a,f   Mittelkotter U ^b   Zimmermann, A ^c   Lachmann, A ^d   Kohler L ^e   Kullmann, K H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c Vivantes Auguste Viktoria Klinikum   (Germany)

^d Department of Urology   (Germany)

^e ROCHE INNOVATION CENTER MUNICH   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibiotic prophylaxis; Ceftriaxone; Cephalosporins; Colon resection; Cost benefit analysis; Penicillins; Postoperative infection; Risk factors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFOTIAM; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; MEZLOCILLIN; PENICILLIN DERIVATIVE;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; COLON SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033802935     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007309     Document Type: Article

References (13)

1. Rüden H, Gastmeier P, Daschner FD, Schumacher M, Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study. Infection 1997;25:199-202.
2. Focht J, Nösner K, Empfindlichkeitsspektrum von Ceftriaxon und anderen Antibiotika. Krankenhauspharmazie 1997;! 1:531-534.
3. Boxma H, Broekhuizen T, Patka P, Ousting H, Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: The Dutch Trauma Trial. Lancet 1996;347:1133-1137.
4. Lippert H, Gastinger J, Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in Germany. Chemotherapy 1998;44: 355-363.
5. Schardey HM, Kamps TH, RauHG, Baretten G, Gatermann S, Exner H, Schildberg FW, Can oesophago-intestinal leakage develop in the complete absence of bacteria? A comparison of normal and germfree rats. Int J Surg SCI 1997;4:913.
6. Wittmann DH, Condon RE, Prophylaxis of postoperative infections. Infection 1991;19(suppl 6):S337S344.
7. LumleyJW,SiuSK,PillaySP,Stitz R, Kemp RJ, Faoagali J, Nathanson LK, White S, Single dose ceftriaxone as prophylaxis for sepsis in colorectal surgery. Aust NZ J Surg 1992;62: 292-296.
8. Shepherd A, Roberts A, Ambrose NS, Ceftriaxone with metronidazole as single dose prophylaxis in colorectal surgery. Colo-proctology 1986;8:91-94.
9. Gastinger I, Lippen H, Winter M, Hell K, Antibiotikaanwendung bei der operativen Behandlung von 1,927 Patienten mit kolorektalem Karzinom. Coloproctology 1995;17: 18-26.
10. Mittelkötter U, Reith HB, Niemann M, Lee U, Kozuschek W, Effectiveness of different antibiotic prophylaxis on wound healing and hospital stay in colorectal surgery. Sixth Biennial Conference on Antiinfective Agents and Chemotherapy (EICON), May 2-4,1996, Leipzig.
11. Bieser U, Dietrich ES, Frank U, Schwarzer G, Daschner F, Metaanalysis of the perioperative prophylaxis of ceftriaxone versus other cephalosporins. Fifth Annual Cochrane Colloquium, October 8-12, 1997, Amsterdam.
12. LippertH.Gastinger I, Hell K:\Vert einer effizienten Antibiotikaprophylaxe vor dem Hintergrund des neuen Gesundheitsstrukturgesetzes; in: Jahrbuch der Chirurgie. Zülpich, Biermann, 1996, pp 189-196.
13. Reers B, Hell-Türler K, Kullmann KH, Kosteneinsparungen mittels perioperativer Antibiotikaprophylaxe anhand einer Modellrechnung. ZAC 1996;14:233-236.